Status:
COMPLETED
Two Different Tranexamic Acid Regimens in Coronary Artery Bypass Surgery
Lead Sponsor:
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Conditions:
Postoperative Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
The primary aim of this study is to observe the effects of two different methods of administering tranexamic acid (i.v. bolus and i.v. infusion) routinely used intraoperatively in cardiovascular surge...
Eligibility Criteria
Inclusion
- Patients who have coronary artery disease requiring coronary artery bypass surgery with cardiopulmonary bypass and received intravenous tranexamic acid either as a bolus or infusion during the intraoperative period will be included in the study.
- Writen consent obtained
Exclusion
- Patients operated on for reasons other than coronary artery bypass surgery
- Patients who operated on as emergencies
- Patients who have preoperative liver/renal dysfunction or a history of cerebrovascular events
- Patients under the age of 18
- Patients who have coagulation disorder
- Patients who have a history of allergies
- Pregnancy or lactation
- Disabled in spirit or law
Key Trial Info
Start Date :
August 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 21 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05994989
Start Date
August 14 2023
End Date
October 21 2024
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi Yaşargil Education and Research Hospital
Diyarbakır, Turkey (Türkiye), 21070